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Abstract
Background: Although adverse event (AE) monitoring in trials focusses on medical events, social outcomes may be
important in public or social care trials. We describe our approach to reporting and categorising medical and other
AE reports, using a case study trial. We explore predictors of medical and social AEs, and develop a model for
conceptualising safety monitoring.
Methods: The Building Blocks randomised controlled trial of specialist home visiting recruited 1618 first-time
mothers aged 19 years or under at 18 English sites. Event reports collected during follow-up were independently
reviewed and categorised as either Medical (standard Good Clinical Practice definition), or Social (trial-specific
definition). A retrospectively developed system was created to classify AEs. Univariate analyses explored the
association between baseline participant and study characteristics and the subsequent reporting of events. Factors
significantly associated at this stage were progressed to binary logistic regressions to assess independent predictors.
Results: A classification system was derived for reported AEs that distinguished between Medical or Social AEs. One
thousand, three hundred and fifteen event reports were obtained for mothers or their babies (1033 Medical, 257
Social). Allocation to the trial intervention arm was associated with increased likelihood of Medical rather than
Social AE reporting. Poorer baseline psycho-social status predicted both Medical and Social events, and poorer
psycho-social status better predicted Social rather than Medical events. Baseline predictors of Social AEs included
being younger at recruitment (OR = 0.78 (CI = 0.67 to 0.90), p = 0.001), receiving benefits (OR = 1.60 (CI = 1.09 to
2.35), p = 0.016), and having a higher antisocial behaviour score (OR = 1.22 (CI = 1.09 to 1.36), p < 0.001). Baseline
predictors of Medical AEs included having a limiting long-term illness (OR = 1.37 (CI = 1.01 to 1.88), p = 0.046),
poorer mental health (OR = 1.03 (CI = 1.01 to 1.05), p = 0.004), and being in the intervention arm of the trial (OR =
1.34 (CI = 1.07 to 1.70), p = 0.012).
Conclusions: Continuity between baseline and subsequent adverse experiences was expected despite potentially
beneficial intervention impact. We hypothesise that excess events reported for intervention-arm participants is likely
attributable to surveillance bias. We interpreted our findings against a new model that explicates processes that
may drive event occurrence, presentation and reporting. Focussing only upon Medical events may miss the well-
being and social circumstances that are important for interpreting intervention safety and participant management.
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Background
Adverse event (AE) reporting is an integral part of safety
monitoring for clinical trials. However, the processes for
collecting, recording, analysing, and reporting AEs can
be considered to be more complex and less developed
than those processes used when evaluating efficacy in a
trial [1]. Safety monitoring in clinical trials has been
standardised using AE and serious adverse event (SAE)
reporting protocols; for example, The Medicines for Hu-
man Use (Clinical Trials) Regulations 2004, which focus
on medical events of varying severity. Such AEs may or
may not be associated with the intervention. In compari-
son to clinical trials of medicinal products, public health
or social care trials will often evaluate complex interven-
tions in populations with adverse social circumstances;
for example, in deprived populations. Such interventions
may still have unexpected and unwelcome effects. Moni-
toring unintended or unexpected outcomes in such trials
and participant well-being in general will involve out-
comes which are social and psychological in nature in
addition to medical. Systems for monitoring these events
are underdeveloped and inconsistent in public health,
social care, and psychotherapy trials; for example, Dug-
gan et al. (2014) found that the recording of AEs in a
trial of psychological intervention was either not
attempted/reported, or used definitions not entirely suit-
able to the intervention or condition being studied [2].
While some authors have attempted to expand on the
Good Clinical Practice (GCP) definition of AEs and
SAEs to incorporate other types of events [3–6], none of
these have included social events.
The Building Blocks randomised controlled trial evalu-
ated the effectiveness and cost-effectiveness of the Fam-
ily Nurse Partnership (FNP) home-visiting programme
in England [7, 8]. Field and office-based researchers were
responsible for the reporting of AEs on a site level to the
trial team.
Monitoring events in the trial performed two func-
tions. The first was to detect any undesirable conse-
quence of the intervention. FNP is a supportive and
voluntary home-visiting intervention which was not ex-
pected to produce harm, but with up to 64 home visits
to women in often vulnerable circumstances, the inten-
sive and structured approach could have been unwel-
come to some families. The second purpose was to
monitor in general the well-being of research partici-
pants in both trial arms. This included attempting to en-
sure that research processes did not add to participants’
distress if they were experiencing adverse social circum-
stances, and to facilitate optimal trial processes.
The value of monitoring AEs in trials is in detecting
harmful effects attributable to an intervention. However,
this signal may be obscured by other non-relevant fac-
tors that introduce unhelpful ‘noise’. For example, some
studies have found reporting rates of AEs to vary by
country [3], by reporter (e.g. clinician vs. participant) [9],
and by reporting site. Reporting of AEs by health profes-
sionals may depend upon their awareness of the event,
their judgement about the event, and their willingness to
document the event [10]. Variation in reporting AEs
driven by under-developed monitoring systems or incon-
sistent training reduces the potential to adequately
monitor unintended effects of both public health and
other interventions.
In summary, systems for AE monitoring in interven-
tional studies in public health and social care are under-
developed and variation in reports may be due to factors
other than the intervention itself. In this paper our first
aim is to describe our approach to reporting and cate-
gorising Medical and other AE reports in a large public
health trial. Our second aim is to assess variability in
safety reporting, and explore factors associated with the
nature (i.e. the type of event reported), level (i.e. the level
of seriousness) and quality of reporting (for example,
any differences between study sites) in our study sample.
Methods
The Building Blocks trial evaluated the effectiveness of
the FNP programme. The intervention consisted of up
to 64 home visits from a specially trained Family Nurse
during pregnancy and in the 2 years after birth, with the
aim of improving outcomes for the health, well-being
and social circumstances of young, first-time mothers
and their children. The intervention covered core con-
tent areas of personal and environmental health, life
course development, maternal rôle, family and friends
and access to health and social services, including pro-
moting healthy behaviours. The control group did not
receive the intervention and instead received usual ser-
vices, this included the Healthy Child Programme (uni-
versally offered screening, education, immunisation, and
support from birth to the child’s second birthday) deliv-
ered by specialist community public health nurses, and
maternity care appropriate to clinical need. Following
birth the control group continued to receive postnatal
midwifery care and care from existing child health ser-
vices available locally, including an allocated health vis-
itor. Details of the intervention and control conditions,
as well as the full Building Blocks trial methods, can be
found in the trial protocol and results papers [7, 8]. Trial
outcome data was collected during face-to-face inter-
views by local researchers and through telephone inter-
views by staff located in Cardiff who were also
responsible for the reporting of AEs to the trial team.
From the outset, while a primary focus for safety moni-
toring was on Medical AEs, other concerns could have
been noted by both field and office-based researchers.
The collection of AEs was also intended to monitor the
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general well-being of research participants in both trial
arms. For example, we intended to collect information
to allow the trial team to have prior knowledge if they
were contacting participants at difficult times (e.g. if ei-
ther a mother or child was undergoing formal safeguard-
ing procedures). Similarly, during the 24-month follow-
up interview, scoring positively for items indicating ser-
ious abuse on a domestic abuse scale also triggered the
completion of an AE form [11]. Detection of domestic
abuse via this scale triggered the family’s health visitor
being informed, and if ongoing and a new disclosure, re-
sulted in a mandatory referral to social services.
Participants: participants in the Building Blocks trial
were 1618 women aged 19 years or under at recruitment
and expecting their first child. Young maternal age was
used as a programme proxy for a range of poor longer-
term outcomes for both child and mother and is also as-
sociated with socioeconomic deprivation. It was ex-
pected that many trial participants would face
challenging individual personal and social circumstances.
Baseline characteristics of the participants were collected
through a home-based interview prior to randomisation.
Setting: 18 sites in England each comprising partner-
ships between primary healthcare organisations and local
authorities for the purposes of delivering the FNP
programme.
Adverse event reporting: AEs were reported during the
approximately 2.5-year follow-up period by field and
office-based researchers. Field researchers were usually
trained midwives or nurses. They collected trial informa-
tion on outcomes from medical notes as well as in face-
to-face interviews (at baseline and final 24 months’
follow-up). They also had a remit to maintain contact
with participants for the purposes of data collection. The
office-based researchers collected self-report data via
telephone interview at late pregnancy, 6, 12 and 18
months following birth. In both telephone and face-to-
face interviews AE reports were triggered by participant
responses to other open-ended questions or were re-
ported directly from a participant un-prompted. AEs
could also be reported by any other health professional
associated with the trial including Family Nurses (inter-
vention group only) and general practitioners (GPs). To
report AEs a form was completed and sent to the trial
team via secure fax, or emailed to the Data Manager.
The Building Blocks trial Manager or the Chief Investi-
gator and one clinical member of the research team
jointly assessed each form to ascertain the nature, ser-
iousness, causality and expectedness of the AE. Follow-
ing receipt of the initial form, the trial team could
request follow-up data from the reporting site or re-
searcher. Some pregnancy-related events, such as hospi-
talisation due to child birth, and termination of
pregnancy for foetal anomaly, were expected in the
context of the trial and were, therefore, not expected to
be reported as AEs.
Training: prior to the start of recruitment, field and
office-based researchers were trained to collect AEs
using a standardised reporting form and following GCP
guidance. Instructions were included in the data collec-
tion forms (e.g. for the telephone interviews), that
reminded interviewers to enquire about participant well-
being at the start of the interview (as an open question).
Any issues related to well-being at this stage would have
been reported as AEs if appropriate to do so. After varia-
tions in AE reporting rates were observed during the
course of the trial follow-up, additional face-to-face
training was provided to all field researchers.
Aim 1: classifying and coding AEs
For the current analyses we retrospectively developed a
system to classify reported AEs. The Chief Investigator
(MR), Trial Manager (EO-J), Data Manager (GM), Se-
nior Clinical Researcher (JS), a clinical co-investigator on
the Building Blocks trial (JK), and a clinically qualified
qualitative researcher (CW) met to develop a classifica-
tion system following some iterative discussions and re-
view of a sample of submitted AE forms.
Developing the classification: the GCP definitions of
AEs and SAEs were used to initially classify forms. A
distinction was then made between physical and mental
GCP AEs and SAEs as the trial team was interested in
distinguishing between participants’ mental and physical
well-being. Events that did not fit under the GCP defini-
tions but were considered of particular relevance to the
trial were then classified as ‘Social AEs’. These included
safeguarding issues, information related to the child be-
ing fostered or adopted which in these circumstances
may be a proxy for adversity [12], incidents of violence
or aggression towards Family Nurses or field researchers,
and issues that would be important for researchers to
know about before speaking to a participant, such as so-
cial circumstances (both at baseline and any changes
during the course of the trial), and instances when a par-
ticipant scored positively for serious abuse on the do-
mestic abuse scale. Events that were recorded on AE
forms but did not meet the criteria for any of the above
categories were classified as ‘Other events’.
Defining unique events: during classification it was im-
portant to define what constituted a discrete ‘event’ as
some forms were essentially updates to previous reports.
An event was defined as starting from the point of pres-
entation, and continued to be consistently the same
‘condition’ until the end of the event. The end of the
event was defined as when the participant had been ei-
ther discharged from hospital, there was no further at-
tendance or visit required, or no follow-up form was
sent. When forms were sent in relation to the same
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event, the first form sent (by date) was classified, and the
rest of the forms were marked as ‘follow-up’. All forms
related to the same event were reviewed before classify-
ing an event as ‘follow-up’ as any form could include de-
tails that would change an event’s classification. If this
was the case the rater would then classify the event
using the most serious classification, and thus these
events were analysed on the basis of the greater degree
of severity. Where more than one event was reported on
a form, each event was classified separately.
Coding forms: after the final classification system was
agreed, the AE forms were coded by a clinically qualified
qualitative researcher (CW) from outside the research
team but who had been involved in developing the clas-
sification system. A second rater (GM) coded a 10% ran-
dom selection of events to ascertain reliability of the
classification system using Cohen’s Kappa [13].
Aim 2: exploring sources of variation in rate of reporting
AEs
We hypothesised that:
 Poorer psycho-social status and health at baseline
will be associated with higher reported rates of both
Medical and Social AEs (baseline variables thought
to reflect poorer psycho-social status listed below)
 Poorer psycho-social status at baseline will more
likely be associated with Social rather than Medical
AEs
 AEs reports will be more likely for those in the trial
intervention arm (hypothesised to be due to
surveillance bias, having received up to 64 visits
from a family nurse)
Rate of AE reporting will vary by trial site (due to
various system level differences between sites which
could include variability in research nurse approach;
e.g. actual funded time, total number of participants
at site being monitored, quality of links to local
Family Nurses or other local staff). Site was a
predictor we sought to modify during the course of
the trial, but despite our efforts differences in site
were not eradicated.
Baseline variables that we considered to indicate
poorer psycho-social status were younger age at recruit-
ment, the woman’s status being classified as NEET (Not
in Education, Employment, or Training), being in receipt
of benefits, having ever been homeless, having lower
socio-economic status (Index of Multiple Deprivation
score), lower family and lower personal subjective social
status, lower relationship quality, lower social support,
lower family resources, lower self-efficacy, and lower
adaptive functioning.
All participants were categorised as having experi-
enced either no, or at least one Social AE. They were
also categorised as having experienced either no or at
least one Medical AE (regardless of severity). These
formed the two dependent variables in subsequent ana-
lyses. For each dependent variable the following sets of
analyses were performed. Baseline characteristics were
summarised between those who experienced either no
or at least one AE (Social and Medical) using number
(%), mean alongside standard deviation (SD) and median
alongside the 25th to 75th centiles. Baseline characteris-
tics included socio-demographics listed above, e.g. age;
health (e.g. health status, psychological distress) and
group allocation. Logistic regression models were run to
examine univariable associations between baseline char-
acteristics and AEs. Baseline characteristics that were as-
sociated at the 10% significance level were retained and
entered as candidate predictors for the multivariable
model to detect all characteristics independently predict-
ive based on a significance level of 0.05 of AEs. Trial site
was adjusted for by its inclusion as a random effect in all
models. Multi-collinearity in each model between candi-
date predictors was assessed by detecting the tolerance
and its reciprocal, the Variance Inflation Factor (VIF).
As a rule of thumb a VIF of 1 indicates no collinearity
but a VIF greater than 4 (a tolerance of 0.2) might war-
rant further investigation and greater than 10 would in-
dicate that multi-collinearity is a problematic.
Results
Aim 1: classification system for reported AEs
A classification system was derived for reported AEs
(Fig. 1). This distinguished between Medical AEs and
Social AEs. The former were further classified into Phys-
ical or Mental and by severity (i.e. whether or not ser-
ious, severity was determined following the GCP
definition). Social AEs encompassed several distinct cat-
egories, such as safeguarding, but did not further distin-
guish between severity. The reliability of coding reports
to the classification system was high (Table 1) with an
overall Cohen’s Kappa [13] rating of 0.925. Of the 1315
uniquely reported events, 78.6% were Medical AEs (552
SAEs, 481 AEs), 19.5% were coded as Social AEs and a
further 25 (1.9%) were coded as ‘Other’ events.
The number of unique events reported by trial site
and their classification, whether the event was related to
the mother or baby, source of notification, and trial arm
are described in the following paragraphs.
One thousand, three hundred and fifteen completed
forms were sent to the trial team, relating to 667/1618
(41.2%) participants (or their baby(ies)). The number of
events per participant varied considerably from 0 to 27.
On average, 0.81 events were reported for each partici-
pant (Table 2). For Physical SAEs the rates of reported
Moody et al. Trials          (2019) 20:804 Page 4 of 16
events ranged from 0.07 to 1.53 per participant (a more
than 20-fold difference in similarly sized trial sites).
None of the Social AEs were related to violence or ag-
gression towards Family Nurse or Researchers (as self-
reported by the professionals), and most events related
to safeguarding (Table 3).
Events related to mothers accounted for 36.7%, events
related to baby(ies) accounted for 42.7%, and events re-
lated to both mother and baby(ies) accounted for 20.6%.
614/1315 (46.69%) of events were recorded as being be-
fore the birth of the Building Blocks baby(ies).
Over 90% of events were reported by field and office-
based researchers as opposed to other health profes-
sionals involved with the trial (Table 4).
After variations in AE reporting rates were observed
during the course of the trial follow-up, additional face-
to-face training was provided on two dates to all field re-
searchers. The number of events reported before the
first training day was 1030 (78.3%), the number of events
reported between the two training dates (including first
training date) was 14 (1.1%), and the number of events
reported post training (including the second training
date) was 109 (8.3%); 162 (12.3%) events were reported
that did not contain an event date. The referenced here
is event date, rather than reporting date; therefore, cau-
tion should be taken as the event may have taken place
sometime before it was reported.
Aim 2: analysis of variation in rate of reporting AEs
Baseline characteristics were compared for participants
with and without at least one Social AE (Table 5) and
for participants with and without at least one Medical
event (either AE or SAE) (Table 6).
Numerous baseline characteristics were identified to
be associated with Social AEs including younger
mothers, lower family and personal subjective social
Fig. 1 Adverse event (AE) classification in the Building Blocks trial
Table 1 Reliability of Building Blocks adverse event (AE)
classification system
Form classification Agreement (Cohen’s Kappa [13])
SAE Physical 0.923
SAE Mental 135/137 = 99%a
AE Physical 0.950
AE Mental 0.717
Social AE 0.936
Other event 136/137 = 99%a
Total 0.925
acell counts were too low to calculate a Kappa. SAE serious adverse event
Moody et al. Trials          (2019) 20:804 Page 5 of 16
status, NEET, being in receipt of benefits, homelessness,
lower self-efficacy and social support, difficulty in at
least one basic skill, lower quality of life, having a limit-
ing long-term illness, more likely to have substance
abuse, antisocial behaviour, lower relationship quality
and family resources and worse psychological distress
(Table 5). No multi-collinearity was found between any
of the candidate predictors in the multivariable model
(VIF = 1.26). Three predictors were found to be inde-
pendently associated based on a significance level of 0.05
with Social AEs after adjusting for all other candidate
predictors. Participants with at least one Social AE were
more likely to be younger at recruitment (odds ratio
(OR) = 0.78 (CI = 0.67 to 0.90), p = 0.001), to receive wel-
fare benefits (OR = 1.60 (CI = 1.09 to 2.35), p = 0.016),
and have a higher score on a measure for antisocial
behaviour (OR = 1.22 (CI = 1.09 to 1.36), p < 0.001)
(Table 5).
For Medical S/AEs, fewer predictors were apparent at
univariable level including a higher deprivation score,
less than perfect health, a limiting long-term illness, dif-
ficulty in at least one basic skill and having at least one
adaptive functioning burden, antisocial behaviour, more
psychological distress and randomised to receive FNP
(Table 6). Again no collinearity was found between any
of the candidate predictors in the multivariable model
(VIF = 1.09). Three predictors of Medical S/AEs
remained based on a significance level of 0.05 after
adjusting for all other candidate predictors in the model
(Table 6).
Participants with at least one Medical S/AE were more
likely to have a limiting long-term illness (OR = 1.37
Table 2 Number of events per participant within each site
Number of events per participant by site and classification of event
Site ID Number of participants per site Physical SAEs Mental SAEs Physical AEs Mental AEs Social AEs Other events Total (all classifications)
1 43 0.91 0.02 1.35 0.05 0.26 0.05 2.63
2 49 0.53 0 0.49 0 0.04 0 1.06
4 143 0.14 0 0.10 0.01 0.08 0.01 0.35
5 39 0.33 0 0.38 0 0.30 0.03 1.04
7 54 0.07 0.02 0.02 0 0.17 0.02 0.30
8 39 0.26 0 0 0.05 0.03 0 0.33
9 47 0.32 0 0.21 0 0.23 0.02 0.79
10 113 0.57 0.02 0.19 0.02 0.09 0 0.88
21 115 0.12 0 0 0 0.12 0.01 0.25
22 68 1.53 0.03 1.77 0.06 0.42 0.04 3.85
23 99 0.19 0.02 0.33 0 0.04 0 0.59
24 93 0.19 0 0.05 0.01 0.18 0.01 0.45
25 150 0.31 0.01 0.07 0 0.17 0.02 0.59
26 35 0.09 0 0 0 0.03 0 0.11
27 142 0.27 0 0.42 0.03 0.08 0 0.80
28 139 0.35 0.01 0.11 0.05 0.41 0.04 0.97
29 117 0.23 0 0.03 0.03 0.15 0.02 0.47
30 133 0.23 0 0.45 0.01 0.09 0.01 0.80
Total 1618 0.33 0.01 0.28 0.02 0.16 0.01 0.81
AE adverse event, SAE serious adverse event
Table 3 Details of events classified as Social adverse events (AEs)
Social AE detail (primary reason) Number of events (%) Intervention Control
Adoption/fostering 19 (7.4%) 10 (7.8%) 9 (7.0%)
Composite Abuse Scale identified serious domestic abuse during 2-year interview 33 (12.8%) 13 (10.1%) 20 (15.6%)
Domestic abuse 35 (13.6%) 17 (13.2%) 18 (14.1%)
Safeguarding of mother or child 168 (65.4%) 87 (67.4%) 81 (63.3%)
Social conditions 2 (0.8%) 2 (1.6%) 0 (0.0%)
Total 257 129 128
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(CI = 1.01 to 1.88), p = 0.046), were more likely to score
higher on a measure of psychological distress/mental
health (OR = 1.03 (CI = 1.01 to 1.05), p = 0.004), and
were more likely to be in the intervention arm of the
trial (OR = 1.34 (CI = 1.07 to 1.70), p = 0.012).
Missing data was limited as baseline trial data was well
completed (apart from two variables; NEET and rela-
tionship quality) and these were omitted from the multi-
variable analyses.
Discussion
Most AEs reported to the Building Blocks trial were
classified as being Medical SAEs or AEs of a physical na-
ture. However, our finding that over 19% of events were
Social AEs supports the idea that the GCP definition of
AEs and SAEs cannot capture all events related to well-
being and social circumstances that might be important
for a public health or social care trial.
Reporting of AEs in trials requires a number of inter-
related processes to occur (Fig. 2). First, there has to be
a reportable event; therefore, an ‘event’ needs to be de-
fined. Pre-existing factors related to the individual may
affect this; for example, ongoing or intermittent ill-
health which may or may not be related to the individ-
ual’s trial eligibility. Factors arising during the course of
the trial will also affect this, perhaps most notably, but
not solely, exposure to the intervention. Second, events
need to be recognised as reportable, either by the indi-
vidual participant or by a relevant professional. The piv-
otal factors at this stage are how observable the event is,
and its severity. Third, a decision needs to be made to
formally report. This may involve decision-making by
the participant as well as a professional and key to this
will be an assessment of relevance (i.e. is the event of
sufficient importance?). This is of course a judgement
that can be dependent on many factors; e.g. value placed
on the particular event, and is it within the scope of
interest of the trial? Most of this is pre-defined. Finally,
a mechanism needs to facilitate capture of the event. As
we have seen in our trial, mechanisms for capture in-
clude direct reporting (e.g. to field or office-based re-
searchers using standardised forms), identification
through review of routine records, or identification via
screening questions.
How well a trial system can capture with precision all
relevant events will depend on adequate progression
through each of the stages described above. Clinical tri-
als of investigational medicinal products, which may be
most concerned with reporting serious Medical AEs,
may fare better in adequately progressing through these
required processes than trials of complex interventions
where unexpected and undesirable impacts may be less
tangible and arise within a broader social context. Defin-
ing undesirable impacts may be more complex in public
health or social care trials, and the use of Public and Pa-
tient Involvement to assist with definitions may be par-
ticularly useful in some cases.
We hypothesised that lower baseline psycho-social sta-
tus or poorer health status may increase the likelihood
of both Medical and Social AEs. This relates to the first
step of our model (i.e. pre-existing factors). Participants
with existing conditions are more likely to continue or
repeat experience of that condition. We also hypothe-
sised that poorer psycho-social status would be a better
predictor of Social AEs rather than of Medical AEs or
SAEs, and this hypothesis was also supported. Our third
hypothesis was that participants with at least one re-
ported AE or SAE, regardless of whether Medical or So-
cial event, are more likely to be in the intervention arm.
This relates to the Recognition and Decision-making
steps in our model. Women in receipt of intervention
were regularly in contact with a health professional who
in turn also promoted her access to supportive services.
The personal relationship between a participant and her
Family Nurse would have meant an increased number of
opportunities for observing events, and would also have
increased the likelihood of the women disclosing a con-
cern, which they may not have otherwise presented to
Table 4 Source of event notification
Notifier Total number of events reported (%) Intervention Control
Field researcher 1125 (85.5%) 603 (83.5%) 522 (88.0%)
Office-based researcher 75 (5.7%) 32 (4.4%) 43 (7.3%)
Family nurse 68 (5.1%) 67 (9.3%) 1 (0.2%)
Health visitor 14 (1.1%) 0 (0.0%) 14 (2.4%)
Midwife 5 (0.4%) 2 (0.3%) 3 (0.5%)
GP 1 (0.1%) 0 (0.0%) 1 (0.2%)
Other medical professional 1 (0.1%) 0 (0.0%) 1 (0.2%)
Unknown job rôle 1 (0.1%) 1 (0.1%) 0 (0.0%)
No name on form 25 (1.9%) 17 (2.4%) 8 (1.3%)
Total 1315 722 593
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Table 5 Baseline characteristics of participants with and without at least 1 Social adverse event (AE)
At least 1 Social AE
N = 208
Participants without a Social
AE
N = 1410
Unadjusted ORa (95%
CI), p value
Adjusted ORb (95%
CI), p value
n Median (25th to 75th
centile) or %
n Median (25th to 75th
centile) or %
Baseline characteristic
Maternal age (years) 208 17.6 (16.7 to 18.6) 1410 17.9 (17.0 to 18.8) 0.84 (0.74 to 0.94),
0.004
0.78 (0.67 to 0.90),
0.001
Ethnicity Overall p value =
0.189
White background 190 91.3 1235 87.6 Ref
Mixed background 13 6.2 76 5.4 1.07 (0.57 to 2.02),
0.834
Asian background 3 1.4 24 1.7 0.59 (0.15 to 2.26),
0.439
Black background 2 1.0 69 4.9 0.22 (0.05 to 0.95),
0.042
Other background 0 0.0 6 0.4 –
Relationship status Overall p value =
0.275
Married 2 1.0 18 1.3 Ref
Separated 27 13.0 138 9.8 2.13 (0.44 to 10.30),
0.346
Closely involved/boyfriend 156 75.0 1066 75.6 1.46 (0.32 to 6.78),
0.627
Just friends 23 11.0 188 13.3 1.20 (0.24 to 5.87),
0.823
Live with father of baby
No 127 68.3 985 76.1 Ref
Yes 59 31.7 309 23.8 1.32 (0.94 to 1.88),
0.113
Missing 22 116
Family subjective social status 207 5.4 (5.0 to 7.0) 1400 5.6 (5.0 to 7.0) 0.90 (0.83 to 0.99),
0.022
1.01 (0.91 to 1.12),
0.879
Personal subjective social status 208 6.7 (5.0 to 8.0) 1403 6.9 (6.0 to 8.0) 0.92 (0.85 to 1.00),
0.041
0.96 (0.88 to 1.05),
0.386
NEETc:
No 89 53.9 720 59.3 Ref
Yes 76 46.1 495 40.7 1.41 (1.00 to 1.98),
0.050
Not applicable 43 195
Receive any benefits
No 112 53.8 920 65.3 Ref Ref
Yes 96 46.2 488 34.7 1.61 (1.19 to 2.18),
0.002
1.60 (1.09 to 2.35),
0.016
Missing 0 2
Ever been homeless
No 141 67.8 1163 82.5 Ref Ref
Yes 67 32.2 247 17.5 2.08 (1.49 to 2.91),
< 0.001
1.50 (0.99 to 2.28),
0.059
Socio-economic status: Index of
Multiple Deprivation Scored
207 39.1 (24.5 to 51.6) 1399 39.2 (25.2 to 52.1) 1.01 (1.00 to 1.02),
0.188
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Table 5 Baseline characteristics of participants with and without at least 1 Social adverse event (AE) (Continued)
At least 1 Social AE
N = 208
Participants without a Social
AE
N = 1410
Unadjusted ORa (95%
CI), p value
Adjusted ORb (95%
CI), p value
n Median (25th to 75th
centile) or %
n Median (25th to 75th
centile) or %
EQ5D-Binary
Less than perfect health 97 46.6 488 34.7 Ref Ref
Perfect health 111 53.4 919 65.3 0.70 (0.51 to 0.95),
0.023
0.94 (0.63 to 1.38),
0.739
Not answered 0 3
Self-rated health Overall p value =
0.414
Excellent 28 13.5 235 16.7 Ref
Good 143 68.8 942 66.8 1.23 (0.79 to 1.91),
0.355
Fair 32 15.4 220 15.6 1.17 (0.67 to 2.04),
0.573
Poor 5 2.4 13 0.9 2.61 (0.82 to 8.27),
0.103
Limiting long-term illness:
No 160 76.9 1179 83.6 Ref Ref
Yes 48 23.1 231 16.4 1.38 (0.96 to 2.00),
0.086
1.17 (0.77 to 1.77),
0.460
Generalized Self-efficacy Scalee 204 29.2 (27.0 to 32.0) 1388 30.1 (28.0 to 33.0) 0.95 (0.92 to 0.98),
0.002
Adaptive functioningf
Difficulty in at least 1 basic skill
No 137 65.9 1048 74.5 ref Ref
Yes 71 34.1 359 25.5 1.70 (1.23 to 2.35),
0.001
1.36 (0.94 to 1.96),
0.103
Missing 0 3
Adaptive functioningf
Had 3 or less life skills (out of 5)
No 157 75.8 1021 72.7 Ref
Yes 50 24.2 384 27.3 0.92 (0.65 to 1.31),
0.648
Missing 1 5
Adaptive functioningf
At least 1 burden
No 134 65.0 997 71.2 Ref
Yes 72 35.0 404 28.8 1.25 (0.91 to 1.72),
0.172
Missing 1 9
Substance abuseg 199 1.6 (0.0 to 3.0) 1399 1.3 (0.0 to 2.0) 1.23 (1.02 to 1.24),
0.014
0.93 (0.83 to 1.05),
0.233
Antisocial behaviour Score 205 3.1 (2.0 to 4.0) 1404 2.3 (1.0 to 4.0) 1.30 (1.19 to 1.42),
< 0.001
1.22 (1.09 to 1.36),
< 0.001
Social support 205 81.5 (73.7 to 96.1) 1398 85.4 (77.6 to 98.7) 0.99 (0.98 to 0.996),
0.003
1.00 (0.99 to 1.01),
0.969
Relationship quality 171 26.9 (24.0 to 31.0) 1106 28.2 (26.0 to 32.0) 0.94 (0.91 to 0.97),
< 0.001
Not includedh
Family resources 203 12.4 (9.5 to 15.0) 1348 13.5 (11.0 to 17.0) 0.93 (0.90 to 0.97),
< 0.001
0.96 (0.92 to 1.00),
0.063
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another health professional or researcher. We found trial
arm to be a predictor of Medical S/AE, but not of Social
AEs, thus providing partial support for our hypothesis. It
is possible that expected social concerns may have sim-
ply been addressed within the routine remit of the Fam-
ily Nurse’s work, rather than being documented or
reportable as a trial AE. Our final hypothesis was that
site-level differences would affect reporting of both Med-
ical S/AEs and Social AEs. While we have been unable
to fully explore this facet of the process in our analysis,
factors that may vary by site cumulatively impact upon
successive stages of event processing and are discussed
more fully below. These factors could include local cap-
acity, experience of field researchers and adequacy of
training cascaded to local professional and research staff.
Table 7 summarises our hypotheses in relation to our
results.
How trial teams can optimise the capture of AEs is
represented to the right of our model (Fig. 2). These in-
clude well-established practices such as having a clearly
defined set of criteria for reportable events, awareness-
raising amongst key stakeholders and provision of ac-
cessible reporting forms. While for clinical trials of med-
ical interventions, the scope of reportable events is well
established, this will need to be expanded for trials of
complex public health and social care interventions. Ad-
herence to these processes will need to be supported
through training, performance monitoring and feedback
mechanisms which could involve one-to-one review of
reported events and/or systematic assessment of sets of
reported events. These combined processes are most
likely to impact upon the Recognition, Decision-making
and Reporting stages of the model.
Taking our trial as an example, process optimisation
would involve training field and office-based researchers
to ensure that AEs were collected in a standardised man-
ner. It is important to collect AE data in a standardised
manner to enable researchers to pool evidence from
large trials [3], and standardisation also allows re-
searchers to compare efficacy outcomes with AEs re-
ported. There were some variations reported in the ways
that AEs were collected in the Building Blocks trial, and
this may have had a bearing on the proportion of AEs
collected from each site. While advice was provided at
the outset about what was reportable as an AE (i.e. a
clear definition of what an event is), we revised this ad-
vice based on early experiences in the trial. Researchers
were responsible for asking local health professional
teams; for example, Family Nurses, to alert them to any
AEs concerning Building Blocks participants. Stickers
were also placed inside participant hospital notes alert-
ing hospital staff to contact the researcher with details of
any AEs. Having accessible reporting forms and other
guidance defining what is reportable is key. Even though
field and office-based researchers were trained in the
collection of AEs, verbal reports alluded to some vari-
ation in the way AEs that were collected in practice.
Some researchers reviewed hospital notes for AEs when
collecting data for the birth data collection phase of the
trial. While this was valuable for identifying some other-
wise unreported events, clearer direction at the outset to
target this activity would have reduced some apparent
unhelpful variation by site. Scoring positively for items
indicating serious abuse on a domestic abuse scale also
triggered the completion of an AE form, and formally
triangulating between data sources to identify AEs where
possible might be another way to improve the collection
of AEs. It should also be noted that some events have a
subjective element; for example, events related to mental
health are probably more subjective than those relating
to physical health, and the recognition of an event may
be affected by the subjectivity of that event. Other re-
searchers have written about the importance of system-
atic collection of events in medical trials to produce
Table 5 Baseline characteristics of participants with and without at least 1 Social adverse event (AE) (Continued)
At least 1 Social AE
N = 208
Participants without a Social
AE
N = 1410
Unadjusted ORa (95%
CI), p value
Adjusted ORb (95%
CI), p value
n Median (25th to 75th
centile) or %
n Median (25th to 75th
centile) or %
Psychological distress/mental health 207 23.0 (18.0 to 27.0) 1402 21.3 (16.0 to 26.0) 1.03 (1.01 to 1.06),
0.003
1.01 (0.98 to 1.04),
0.585
Arm
Control 100 48.1 710 50.4 Ref
Intervention 108 51.9 700 49.6 1.10 (0.81 to 1.48),
0.545
aOR predicts a Social AE and adjusted for site; bAdjusted for site and all other candidate predictors in model; cDefinition of Not in Education, Employment, or
Training (NEET): not in education employment or training status (applicable only to those whose academic age is > 16 years at baseline interview); dHigher IMD
score indicated more deprivation; eHigher score indicates higher level of self-efficacy; fHigher score indicates better management of day-to-day lives and routines
(for each of the three sub-scales); gCRAFFT screening test for substance related risks and problems in adolescents; h due to question only applicable to those in
a relationship
Odds ratios (ORs) bolded and in italics indicate variable significant at 10% at univariable level and remained so at multivariable level
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Table 6 Baseline characteristics of participants subsequently with and without at least 1 Medical adverse event (AE) or serious
adverse event (SAE)
At least 1 Medical SAE/AE
N = 532
Participants without a
Medical SAE/AE
N = 1086
Unadjusted ORa (95%
CI), p value
Adjusted ORb (95%
CI), p value
Baseline characteristic n Median (25th to 75th
centile) or %
n Median (25th to 75th
centile) or %
Maternal age (years) 532 17.9 (16.9 to 18.9) 1086 17.8 (16.9 to 18.8) 1.05 (0.97 to 1.15),
0.226
Ethnicity Overall p value = 0.240
White background 473 88.9 952 87.7 Ref
Mixed background 34 6.4 55 5.1 1.45 (0.90 to 2.36),
0.130
Asian background 12 2.3 15 1.4 1.69 (0.68 to 4.22),
0.259
Black background 11 2.1 60 5.5 0.65 (0.30 to 1.39),
0.265
Other background 2 0.4 4 0.4 1.59 (0.27 to 9.45),
0.609
Relationship status Overall p value = 0.847
Married 8 1.5 12 1.1 Ref
Separated 51 9.6 114 10.5 0.73 (0.26 to 2.06),
0.557
Closely involved/boyfriend 407 76.5 815 75.0 0.67 (0.32 to 1.80),
0.426
Just friends 66 12.4 145 13.4 0.67 (0.24 to 1.88),
0.448
Live with father of baby
No 349 71.8 763 76.8 Ref
Yes 137 28.2 231 23.2 1.16 (0.88 to 1.52),
0.285
Missing 46 92
Family subjective social status 527 5.7 (5.0 to 7.0) 1080 5.7 (5.0 to 7.0) 1.00 (0.93 to 1.07),
0.916
Personal subjective social status 529 6.8 (6.0 to 8.0) 1082 6.9 (6.0 to 8.0) 0.98 (0.92 to 1.04),
0.439
NEETc
No 279 61.0 530 57.4 ref
Yes 178 39.0 393 42.6 0.98 (0.76 to 1.26),
0.869
Not applicable 75 163
Receive any welfare benefits
No 346 65.0 686 63.3 Ref
Yes 186 35.0 398 36.7 1.02 (0.81 to 1.30),
0.848
Missing 0 2
Ever been homeless
No 419 78.8 885 81.5 Ref
Yes 113 21.2 201 18.5 1.24 (0.93 to 1.64),
0.146
Socio-economic status: Index of Multiple
Deprivation Scored
528 39.1 (25.9 to 51.3) 1078 39.2 (24.8 to 52.6) 1.01 (0.99 to 1.01),
0.078
1.01 (0.998 to 1.01),
0.106
EQ5D-Binary
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Table 6 Baseline characteristics of participants subsequently with and without at least 1 Medical adverse event (AE) or serious
adverse event (SAE) (Continued)
At least 1 Medical SAE/AE
N = 532
Participants without a
Medical SAE/AE
N = 1086
Unadjusted ORa (95%
CI), p value
Adjusted ORb (95%
CI), p value
Baseline characteristic n Median (25th to 75th
centile) or %
n Median (25th to 75th
centile) or %
Less than perfect health 220 41.4 365 33.7 Ref Ref
Perfect health 312 58.6 718 66.3 0.73 (0.58 to 0.93),
0.012
0.98 (0.74 to 1.29),
0.881
Not answered 0 3
Self-rated health Overall p-value = 0.141
Excellent 86 6.2 177 16.3 Ref
Good 345 64.8 740 68.1 1.00 (0.73 to 1.36),
0.985
Fair 92 17.3 160 14.7 1.20 (0.81 to 1.79),
0.359
Poor 9 1.7 9 0.8 2.84 (1.02 to 7.95),
0.046
Limiting long-term illness:
No 416 78.2 923 85.0 Ref ref
Yes 116 21.8 163 15.0 1.53 (1.14 to 2.06),
0.005
1.37 (1.01 to 1.88),
0.046
Generalized Self-efficacy Scalee 526 30.0 (27.0 to 33.0) 1066 30.0 (28.0 to 33.0) 1.00 (0.97 to 1.02),
0.869
Adaptive functioningf
Difficulty in at least 1 basic skill
No 372 70.3 813 74.9 ref Ref
Yes 157 29.7 273 25.1 1.38 (1.07 to 1.78),
0.013
1.18 (0.91 to 1.54),
0.219
Missing 3 0
Adaptive functioningf
Had 3 or less life skills (out of 5)
No 387 72.9 791 73.2 ref
Yes 144 27.1 290 26.8 1.11 (0.87 to 1.43),
0.404
Missing 1 5
Adaptive functioningf
At least 1 burden
No 354 67.0 777 72.0 Ref Ref
Yes 174 33.0 302 28.0 1.26 (0.98 to 1.61),
0.069
1.09 (0.84 to 1.41),
0.543
Missing 3 7
Substance abuseg 513 1.3 (0.0 to 2.0) 1025 1.4 (0.0 to 2.0) 0.98 (0.91 to 1.06),
0.612
Antisocial behaviour Score 528 2.4 (1.0 to 4.0) 1081 2.4 (1.0 to 4.0) 1.06 (0.99 to 1.13),
0.089
1.01 (0.95 to1.09),
0.689
Social support 526 85.1 (77.6 to 98.7) 1077 84.8 (77.6 to 98.7) 1.00 (0.99 to 1.01),
0.784
Relationship quality 428 28.4 (26.0 to 32.0) 849 28.8 (25.0 to 31.0) 1.00 (0.98 to 1.03),
0.825
Family resources 510 13.3 (11.0 to 16.0) 1041 13.4 (11.0 to 17.0) 0.98 (0.95 to 1.01),
0.145
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reliable data [14] and to prevent biased reporting [15].
The subjectivity of medical events may be a reason for
the slightly lower agreement during classification when
compared to physical events which include more object-
ively observable physical descriptions symptoms/signs/
diagnoses, and for AEs (rather than SAEs) the rôle of
subjective decision-making may be greater as the appar-
ent importance is less severe. In this study, although
reporting systems for SAEs were systematic (i.e. using a
common reporting form) and reporting came via mul-
tiple routes, there was not a wholly systematic process
for their identification. Ensuring that data was collected
in a more systematic way could have been done in a
number of ways in the current trial. For example, we
could have asked researchers to all either periodically
search notes for AEs (this was done by a proportion of
researchers) or to do this at the end of the trial. While
domestic violence was systematically screened for at the
Table 6 Baseline characteristics of participants subsequently with and without at least 1 Medical adverse event (AE) or serious
adverse event (SAE) (Continued)
At least 1 Medical SAE/AE
N = 532
Participants without a
Medical SAE/AE
N = 1086
Unadjusted ORa (95%
CI), p value
Adjusted ORb (95%
CI), p value
Baseline characteristic n Median (25th to 75th
centile) or %
n Median (25th to 75th
centile) or %
Psychological distress/mental health 529 22.4 (17.0 to 27.0) 1080 21.1 (16.0 to 25.0) 1.04 (1.02 to 1.06), <
0.001
1.03 (1.01 to 1.05),
0.004
Arm
Control 243 45.7 567 52.2 Ref Ref
Intervention 289 54.3 519 47.8 1.32 (1.05 to 1.65),
0.016
1.34 (1.07 to 1.70),
0.012
aOR predicts a Social AE and adjusted for site; bAdjusted for site and all other candidate predictors in model; cDefinition of NEET: Not in Education Employment or
Training Status (applicable only to those whose academic age is > 16 years at baseline interview); dHigher IMD: Index of Multiple Deprivation score indicated more
deprivation; eHigher score indicates higher level of self-efficacy; fHigher score indicates better management of day-to-day lives and routines (for each of the three
sub-scales); gCRAFFT screening test for substance-related risks and problems in adolescents;
Odds ratios (ORs) bolded and in italics indicate variable significant at 10% at univariable level and remained so at multivariable level
Fig. 2 A proposed model of adverse event presentation and reporting
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end of the study period and where applicable reported
as an SAE, other items specifically designed to collect
AE data could have been included in the various data
collection stages. Tools such as MedDRA have been
used for safety monitoring in drug trials; something
similar could be used, with supplementary items de-
signed to capture social events. These amendments,
however, would have increased costs and participant
burden and doing so would have to be balanced against
the risk of missing such harms.
Improvements could also have been made in the train-
ing given to field and office-based researchers to ensure
that AE forms were completed in a standardised manner.
The quality of an individual case safety report is
dependent on the accuracy and completeness of the in-
formation gleaned about the case [16], and the same can
be said in the case of AE reporting in the Building
Blocks trial. The need for training on the completion of
a form should be balanced with ensuring that the forms
are self-explanatory as many health professionals com-
pleting the forms will be doing so without receiving any
formal training. For example, as well as field and office-
based researchers, other health professionals and even
participants may provide information on AEs in the trial.
Guidance on determining expectedness of events was
provided during the training; however, some events re-
ported as being ‘unexpected’ were subsequently reclassi-
fied due to the context of the Building Blocks trial.
Horigian et al. [17] listed five principles for defining
AEs in behavioural research and our own study can be
viewed in light of these. Firstly, that they should be
grounded in previous research, and secondly, queries on
AEs should include domains plausibly affected by the in-
terventions being tested. The current study also defined
AEs in light of research, but were more open in what
were accepted as AE reports. This may have caused
some problems with too much interpretation by Re-
search Nurses and too much variation in reporting by
site; this issue was responded to with more training.
Perhaps a framework of possible AEs should be put in
place a priori which then allows for unanticipated AEs
to be observed and reported. Compared to some
psycho-therapeutic settings, home-visiting is a more
complex intervention, may impact on a broader range of
outcomes and not solely for the participant (for example,
there could be an impact on a partner, parent, etc.).
Even though a logic model and previous literature can
inform in advance what AEs may be likely, some flexibil-
ity within an overarching framework is helpful. Thirdly,
monitoring should attempt to assess relatedness between
interventions and AEs, we agree with this but it should
be kept in mind that relatedness is perhaps even harder
to establish when an intervention is delivered over such
a long period of time (2.5 years) and where the interven-
tion (in this case FNP) is also seeking to engage the cli-
ent with a range of other services, social and family
support, this simply adds to the complexity of causation.
We agree with both the fourth principle that systematic
monitoring is essential for identifying unexpected
events, and the fifth, that effective monitoring is a
shared responsibility. In summary, the current piece
of work provides support for Horigian’s model in a
different setting (community-based public heath
within families of young children). As they comment
on the need for the utility of the principles on other
settings in their paper, we provide some evidence of
that generalisability. A robust theory to identify broad
AE domains, in addition to more specific AEs, is es-
sential to capture unexpected AEs, and that training
is even more essential to ensure that. Our study pro-
vides an example of where we aimed to capture AEs,
specifically Medical or Social, although the approach
of Horigian et al (2010) would probably actually ad-
dress both. The approach to monitoring AEs in social
and public health is still limited and variable; our
study perhaps identifies the need to better train staff
to monitor this in more complex intervention settings
rather than with clinical patients.
Table 7 Results in relation to hypotheses
Hypotheses Results
Hypothesis 1: poorer psycho-social status and health at baseline will be
associated with higher reported rates of both Medical and Social AEs
Main predictors of Social AEs: younger age at recruitment, more likely to
receive benefits, having a higher antisocial behaviour score. Main predictors
of Medical S/AEs: ill health at baseline (limiting long-term illness and poorer
mental health)
Hypothesis 2: poorer psycho-social status at baseline will more likely be
associated with Social rather than Medical AEs
Hypothesis supported. Main predictors of Social AEs (related to poorer
psycho-social status): younger age at recruitment, more likely to receive
benefits. No baseline indicators of poorer psycho-social status remained in
the model for the Medical S/AEs
Hypothesis 3: AEs reports will be more likely for those in the trial
intervention arm
Hypothesis partially supported. Allocation to the intervention arm of the
trial was associated with increased likelihood of Medical S/AE but not with
Social AE reporting
Hypothesis 4: rate of AE reporting will vary by trial site Partially supported although we have been unable to fully explore this
AE adverse event, SAE serious adverse event
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Strengths and limitations
We have developed a simple classification scheme for
monitoring reports of AEs, which explicitly accommo-
dates social as well as medical events. This has been de-
veloped over the course of an ongoing trial and,
therefore, benefits from review and assessment of actual
reports rather than hypothetical examples. Constructing
the classification has benefited from the input of the trial
team tasked with AE monitoring (including clinical in-
put) which has also been involved in training research
staff in collating reports in the field. The experience of
discussing the purpose and practice of AE monitoring
with this specific trial population has helped to clarify
the purpose and scope of event monitoring. While the
classification reflects a particular public health interven-
tion and trial population, it nevertheless provides an ex-
ample of how the existing GCP standard approach to
reporting Medical AEs can be expanded to reflect the
needs of a specific trial. Finally, while our classification
distinguished reliably between Medical and Social AEs, a
small number of ‘Other events’ were categorised as nei-
ther and excluded from further analysis. It is possible
that further details of the reported event or further re-
view of the report received would have resulted in re-
classification as either a Medical or a Social event.
However, it is probable that other circumstances for trial
participants would still be of some logistical or clinical
value and, therefore, important to monitor.
The presented analysis benefited from a large sample
which was well characterised at baseline, and dependent
outcomes produced following a reliable coding process.
Our examination of predictors was limited by the large
number of levels for the ‘principal site’ variable. There-
fore, we are unable to conclude whether apparent vari-
ation in reporting by sites could have been due to
differences in trial participants between sites, or due to
site-level factors such as the local researcher. Given the
large variation in event reporting rates between sites
with similarly sized participant samples it seems likely
that non-participant-related factors are likely to be influ-
encing reporting rates. This is important as it would rep-
resent unhelpful noise in an attempt by investigators to
accurately monitor safety and well-being for trial
participants.
Conclusions
Active systematic safety monitoring in public health and
social care trials which additionally focus on Social AEs
is rarely reported. In public health and social care trials,
it is likely that there will be adverse experiences that are
not medical but may reflect social circumstances. A sys-
tem of safety monitoring should be considered which
would include both Medical and Social AEs. We recog-
nise that this may result in a valid decision not to
actively monitor AEs based, for example, on likely fre-
quency and severity. Collecting social events needs to be
tailored to the circumstances of the trial and to reflect
how the information is likely to be used. This could in-
clude assessing any unexpected adverse consequences of
the intervention, more general safeguarding of partici-
pant well-being during a trial, identifying matters that
need to be considered in running the trial (e.g. to avoid
contacting participants in distress) and also exploring
more broadly the mechanism and broader impacts of an
intervention (Fig. 2). How information about AEs will be
used should be clearly stated by researchers and guide
decision-making about how best to resource and support
high-quality data capture.
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